Neurosciences Program, Hematology and Oncology Center, Cook Children's Medical Center, 901 Seventh Avenue, Suite 220, Fort Worth, TX 76104, USA.
J Neurooncol. 2011 May;102(3):509-14. doi: 10.1007/s11060-010-0350-2. Epub 2010 Aug 21.
DiGeorge syndrome, or velocardiofacial syndrome (DGS/VCFS), is a rare and usually sporadic congenital genetic disorder resulting from a constitutional microdeletion at chromosome 22q11.2. While rare cases of malignancy have been described, likely due to underlying immunodeficiency, central nervous system tumors have not yet been reported. We describe an adolescent boy with DGS/VCFS who developed a temporal lobe pleomorphic xanthoastrocytoma. High-resolution single nucleotide polymorphism array studies of the tumor confirmed a constitutional 22q11.21 deletion, and revealed acquired gains, losses and copy number neutral loss of heterozygosity of several chromosomal regions, including a homozygous deletion of the CDKN2A/B locus. The tumor also demonstrated a common V600E mutation in the BRAF oncogene. This is the first reported case of a patient with DiGeorge syndrome developing a CNS tumor of any histology and expands our knowledge about low-grade CNS tumor molecular genetics.
22q11.2 染色体缺失导致的 DiGeorge 综合征或心脏面部综合征(DGS/VCFS)是一种罕见的常染色体隐性遗传病,其主要表现为 22q11.2 染色体微缺失。虽然有报道罕见的恶性肿瘤病例,可能是由于潜在的免疫缺陷,但中枢神经系统肿瘤尚未见报道。本文报道了一例 DiGeorge 综合征青少年患者,其发生了颞叶多形性黄色星形细胞瘤。对肿瘤的高分辨率单核苷酸多态性微阵列研究证实存在 22q11.21 染色体缺失,并且还发现了几个染色体区域的获得性增益、缺失和杂合性丢失,包括 CDKN2A/B 基因座的纯合缺失。肿瘤还显示 BRAF 致癌基因的 V600E 常见突变。这是首例 DiGeorge 综合征患者发生任何组织学类型的中枢神经系统肿瘤的病例,并且扩展了我们对低级别中枢神经系统肿瘤分子遗传学的认识。